The team at Freshfields Bruckhaus Deringer LLP was strengthened in 2024 by the September addition of Kevin Yingling, formerly of Google, and former FTC Commissioner Christine Wilson in February. Wilson now heads the Washington DC-based team, which works closely with global colleagues to handle multi-jurisdictional deal clearances. The team regularly handles high value deals for clients including eBay, Johnson & Johnson, and AstraZeneca, and represented Viterra Limited on the global merger control and foreign investment regulation aspects of its $34 billion merger with Burge Limited. Mary Lehner remains a go-to for large companies in their merger control matters, and Meghan Rissmiller is particularly noted for her work in the telecoms and life sciences arenas. Jennifer Mellott works between DC and Brussels, advising clients on multi-national transactions, and Justin Stewart-Teitelbaum also has experience representing clients in mergers before the European Commission. Jamillia Ferris departed the team in May 2024.
Legal 500 Editorial commentary
- Profile
Key clients
- Hewlett Packard Enterprise Company (HPE)
- Canada Pension Plan Investment Board, Viterra Limited, Glencore PLC; British Columbia Investment Management Corporation
- eBay
- Johnson & Johnson
- Razor Group
- JD Sports
- Roivant Sciences
- Sonoco Products Company
- Multiple clients including several of the UN-convened Net Zero alliances; Institutional Investors Group on Climate Change; range of multi-national corporate clients
- AstraZeneca
Work highlights
- Advising Hewlett Packard Enterprise ("HPE") on the global antitrust and regulatory aspects of its $14bn acquisition of Juniper Networks Inc.
- Advising grain company Viterra Limited (“Viterra”), together with affiliates of Glencore PLC (“Glencore”), Canada Pension Plan Investment Board (“CPP Investments”) and British Columbia Investment Management Corporation (“BCI”) on the global merger control and foreign investment regulation aspects of its $34 billion merger with Bunge Limited (“Bunge”).
- Advised Johnson & Johnson on its $2bn acquisition of Ambrx Biopharma.
Lawyers
Practice head
Christine Wilson
Other key lawyers
Mary Lehner; Meghan Rismiller; Justin Stewart-Teitelbaum; Jan Rybnicek; Justina Sessions; Heather Lamberg